Disc Medicine

Disc Medicine is a clinical-stage biopharmaceutical company developing medicines for haematological diseases; its pipeline includes bitopertin, DISC-0974 and DISC-3405. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06985147 (phase 2, A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)) and NCT05320198 (phase 1/2, Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syn...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.